Vidcast:  https://www.instagram.com/p/DChtPvOJ9da/

Half of those using semaglutide and similar GLP-1 drugs consume fewer alcoholic beverages.  This according to a study presented to the Obesity Society’s 2024 meeting.  Reviewed were the records of more than 14,000 WeightWatcher’s participants who were using the diet drugs for as long as 9 months.  

The data showed that 45% of those using the drugs decreased their use of alcohol, 52% had no change in drinking habits, and 2% increased their alcohol use.  Those who were drinking the most at baseline were most likely to stop drinking.  Diet drug users report a reduced craving for alcoholic drinks but also more severe side effects including hangovers and gastric distress if they did drink.

This adds yet another benefit of GLP-1 drugs to the list already lengthening.  Whether these diet drugs can help treat alcoholism remains to be proven.

https://www.medscape.com/viewarticle/do-patients-anti-obesity-drugs-decrease-alcohol-use-2024a1000kf9

#diet #glp1 #semaglutide #alcohol #weightwatchers